Remuzat, C. | Toumi, M. | Vataire, A.L. | Cetinsoy, L. |
With constant incentives for health care payers to contain their pharmaceutical budgets forecasting has become critically important. Some countries even developed pharmaceutical horizon scanning units. The objective of this project was to build a model to assess net effect of the entrance of new patented medicinal products versus medicinal products going off-patent, with a forecast horizon until 2016, on seven selected EU Member States’ pharmaceutical budgets: France, the UK, Germany, Poland, Portugal, Greece and Hungary.